MDMAR |
|
| Other names | 3',4'-Methylenedioxy-4-methylaminorex |
|---|
| ATC code | |
|---|
|
5-(1,3-benzodioxol-5-yl)-4-methyl-4,5-dihydro-1,3-oxazol-2-amine
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| ChemSpider | |
|---|
| UNII | |
|---|
| CompTox Dashboard (EPA) | |
|---|
|
| Formula | C11H12N2O3 |
|---|
| Molar mass | 220.228 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
CC1C(OC(=N1)N)C2=CC3=C(C=C2)OCO3
|
InChI=1S/C11H12N2O3/c1-6-10(16-11(12)13-6)7-2-3-8-9(4-7)15-5-14-8/h2-4,6,10H,5H2,1H3,(H2,12,13) Key:JFKNBDXNCLMRPL-UHFFFAOYSA-N
|
3',4'-Methylenedioxy-4-methylaminorex (MDMAR) is a recreational designer drug from the substituted aminorex family, with monoamine-releasing effects. It is a potent serotonin–norepinephrine–dopamine releasing agent (SNDRA).